By Eva Kiesler, PhD, Science Writer/Editor | Wednesday, May 22, 2013
Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers.
By Andrea Peirce, BA, Writer/Editor | Thursday, May 16, 2013
Memorial Sloan-Kettering Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancer.
By Julie Grisham, MS, Science Writer/Editor | Monday, April 8, 2013
Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.
By Julie Grisham, MS, Science Writer/Editor | Thursday, March 28, 2013
A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.
By Mark Kris, MD, Chief, Thoracic Oncology Service | Friday, February 8, 2013
Medical oncologist Mark Kris discusses how cancer experts are working to train IBM Watson to help assist medical professionals.
By Media Staff | Wednesday, January 30, 2013
A New York State law that went into effect this month requires radiologists to inform women if they have dense breasts. Dr. Lee answers questions about the concept of breast density and what women should know.
By Memorial Sloan-Kettering | Wednesday, January 16, 2013
Dr. Sclafani, who practices at Memorial Sloan-Kettering Commack, wants newly diagnosed patients to leave her office with hope and with a plan of action for treating the cancer.
By Esther Napolitano, BS, Science Writer/Editor | Wednesday, December 5, 2012
New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.
By Memorial Sloan-Kettering | Wednesday, October 10, 2012
During Breast Cancer Awareness Month, Dr. Lee discusses mammography, breast MRI, and breast ultrasound.
In the Lab
By Media Staff | Friday, August 24, 2012
A new Memorial Sloan-Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
By Memorial Sloan-Kettering | Wednesday, August 15, 2012
Dr. King talks about her research investigating why certain women develop breast cancer and about the long-term relationships she maintains with her patients.
By Memorial Sloan-Kettering | Wednesday, August 8, 2012
Dr. Mehrara talks about the expertise of Memorial Sloan-Kettering plastic surgeons and how patients with breast cancer and head and neck cancer benefit from recent advances in reconstructive surgery.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, July 6, 2012
A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
By Memorial Sloan-Kettering | Monday, June 25, 2012
Dr. Morrow, Chief of Memorial Sloan-Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.
In the Clinic
By Media Staff | Monday, June 4, 2012
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.